Whether you’re looking for something classic that comforts your palate or something to feed your adventurous side, explore the Downtown Phoenix restaurant guide:

Downtown Phoenix Restaurants & Dining Guide

Meals are not provided unless noted, and in some cases a separate fee applies. Below is a listing of what is provided with the registration fee.

Wednesday, November 4, 2026

SITC Regulatory Roundtable

Coffee and tea will be provided.

Thursday, November 5, 2026

The New Frontier of IO Drug Development: Bispecifics, In Vivo CAR T, and Novel Combinations

Coffee and tea will be provided during program breaks. A reception will follow with light refreshments. Beverages will be available for purchase at a cash bar.

Leveraging the Power of Artificial Intelligence to Foster Progress in Immuno-Oncology: Opportunities and Challenges

Coffee and tea will be provided during the program. Lunch is on your own.

41st Anniversary Annual Meeting

Friday, November 6, 2026

Coffee and tea will be provided before the morning general session. 

Coffee and tea will be provided during the afternoon session break.

Lunch

Lunch is available for purchase in the Exhibit and Poster Hall.

Sponsored Symposia

Box lunches are provided for attendees of these sessions.

Poster Viewing and Reception

Beverages will be available for purchase. One drink ticket is included with the registration fee and may be redeemed at either the Poster Reception or the Checkpoints Party.

Saturday, November 7, 2026

Morning

Coffee and tea will be provided prior to the first session.

Coffee and tea will also be provided during the afternoon session break.

Lunch

Lunch is available for purchase in the Exhibit and Poster Hall.

Sponsored Symposia

Box lunches are provided for attendees of these sessions.

Poster Viewing and Reception

Beverages will be available for purchase. One drink ticket is included with the registration fee and may be redeemed at the Poster Reception.

Sunday, November 8, 2026

Coffee and Tea will be provided prior to the first session

Coffee and Tea will be provided during the morning break. 

Visit the Forward Fund Desk to invest in the future of cancer immunotherapy. Pick-up a ribbon or a t-shirt, with every purchase supporting the next generation of scientific leaders.

Location: Sheraton, Valley of the Sun Ballroom Foyer:

• Wednesday, Nov. 4, 2026
  • 11 a.m. - 3 p.m.
• Thursday, Nov. 5, 2026
  • 9:30 a.m. - 4 p.m.

Location: Exhibit Hall Foyer:

• Friday, Nov. 6, 2026
  • 10 a.m.–2 p.m. & 5 p.m. to 7 p.m.
• Saturday, Nov. 7, 2026
  • 10 a.m.–2 p.m. & at the CheckPoint's Party

Sheraton Phoenix Downtown (2nd Level)

• Wednesday, Nov. 4
  •  2nd Level from 11 a.m. - 7 p.m.
• Thursday, Nov. 5
  • 2nd Level from 7 a.m. - 5 p.m.

Phoenix Convention Center

View the PCC Mamava Pod Map > 

Phoenix Convention Center

Phoenix Parking Downtown

Publication

Regular and Early Career Investigator Award Abstracts submitted in conjunction with the 41^st Annual Meeting will be published on Nov. 3, 2026 in the Journal for ImmunoTherapy of Cancer (JITC), SITC’s official journal. Late-Breaking Abstracts will be published on Nov. 6, 2026. All abstracts will also be available on the SITC website.

Oral Abstracts

Abstracts are presented during various Annual Meeting sessions throughout the 41^st Annual Meeting as well as during the Concurrent Basic Research and Clinical Rapid Oral Abstract Presentation Sessions on Friday, Nov. 6 from 12:30–1:30 p.m. and Saturday, Nov. 7 from 12:30–1:30 p.m.

Late-Breaking Abstracts

Late-breaking Abstract oral presentations will be held Friday, Nov. 6 from 11:30 a.m.–12:15 p.m. and Saturday, Nov. 7 from 1:45–3 p.m.

In Person Poster Hall Information

Poster Hall Location

• PCC-North Building-Lower Level-Exhibition Halls

Poster Hall Hours

• Friday, Nov. 6 from 10 a.m.–7 p.m.
• Saturday, Nov. 7 from 10 a.m.–8:10 p.m.

Poster Presentation Hours

• Odd Numbered Posters (Poster Authors are Present)
  • Friday, Nov. 6 from 12:15–1:45 p.m.
  • Friday, Nov. 6 from 5:30–7 p.m.
• Even Numbered Posters (Poster Authors are Present)
  • Saturday, Nov. 7 from 12:15–1:45 p.m.
  • Saturday, Nov. 7 from 6:40–8:10 p.m.

Virtual Poster Hall Information

• Accessing ePosters
  • ePosters will be available on the virtual meeting platform and the SITC 2026 app. Click “ePosters” tile from the main page.
• Navigating ePosters
  • Search ePosters by:
    • Abstract Category
    • Author
    • Title
    • Abstract Number
    • Late-breaking Abstracts
    • Top 150 scored Abstracts
    • Early Career Investigator Award Abstracts
• Global Search: type any search term, author name, etc. in the search field

Opportunities for Questions with Presenters

• Take advantage of the opportunity to interact with ePoster presenters by adding a question or a comment to the Chat Box associated with each ePoster.
• Thank you to those individuals who submitted an abstract to SITC’s 41^st Annual Meeting and to those who dedicated time to review abstracts this year.

Note: If you’re an abstract presenter, view more information on our presenter information page.

Location: Sheraton Phoenix Downtown - 2^nd Level

• Wednesday, November 4, 2026: 11:00 a.m. - 7:00 p.m.
• Thursday, November 5, 2026: 7:00 a.m. - 5:00 p.m.

Location: Phoenix Convention Center - North Building, 300 Level

• Friday, November 6, 2026: 7:00 a.m. - 5:00 p.m.
• Saturday, November 7, 2026: 7:30 a.m. - 5:00 p.m.
• Sunday, November 8, 2026: 7:15 a.m. - 10:00 a.m.

Location: Sheraton

• Network: MarriottBonvoy_Conference
  • Password: SITC2026

Location: Phoenix Convention Center

• Network: SITC2026
  • Password : SITC2026

Select sessions of the 41^st Annual Meeting qualify for Continuing Education Credits. Browse continuing education information for SITC 2026 on our Continuing Education page.

In-person registrants can participate in the onsite meeting and will also be granted access to virtual enduring materials for selected program(s). In-person attendees have access to onsite networking opportunities, the poster hall, and the exhibit hall.

Virtual registrants receive real-time access and enduring materials using a virtual meeting platform. They have access to live-streamed presentations with the ability to participate in live Q&A. The virtual platform includes virtual networking, an ePoster hall, and virtual exhibits.

Yes. Additional programs purchased by in-person attendees can be virtual or in person. The SITC 2026 online registration platform will allow attendees to select from in-person and virtual programs. Questions? Email Showcare at sitc@showcare.com or call 1-866-320-3203.

In-person and virtual attendance are subject to separate rates per SITC policies: SITC 2026 Rates. Refunds for changing from in-person to virtual registration will not be granted past the cancellation deadline of Oct. 7, 2026. There is no deadline to upgrade from virtual to in-person attendance. Contact Showcare at SITC@showcare.com or 1-866-320-3203 to make changes.

All changes and cancellations must be sent in writing via email to SITC@showcare.com. A $50 processing fee will be charged for all cancellations. No refunds will be granted if cancellation is received after Oct. 7, 2026. Special considerations will be given for health or family emergencies if requested in writing no later than Nov. 22, 2026.

All attendees must be registered in order to book housing. Attendees will be able to reserve their housing within the registration process.

All changes and cancellations must be sent in writing to SITC@showcare.com. Changes can also be made by logging into your registration record by 5 p.m. PT on Wednesday, Oct. 7, 2026. No changes will be accepted between Oct. 7 and Oct. 12, 2026, while reservation information is being transferred to the hotels. Cancellations or changes as of Monday, Oct. 12, must be made directly with the hotels on a space-available basis.

Cancellation requests received 72 hours or less prior to arrival and no-shows will forfeit the one-night room & tax deposit. SITC 2026 is not responsible for no-shows or early departure fees charged by the hotels.

Enduring materials (recorded videos and slides) will be available for the programs that an attendee has registered for. Enduring materials will be posted on the virtual meeting platform after each program/session.

SITC follows the CDC Respiratory Virus Guidance to make recommendations for health precautions for in-person meeting attendees. Attendees unable to attend in person due to illness or a positive COVID-19 test can access meeting content online. For hybrid programs, attendees can change from in-person to online-only registration by contacting sitc@showcare.com. Registered attendees will be notified in advance of any changes to precautions or requirements.

Parking is available at the convention center.  Please find details at this link.

Parking at Phoenix Convention Center | Garages & Directions

Parking is also available at our contracted hotel and rates are listed on our housing page.

The SITC contracted hotel do not offer an airport shuttle service. Guests may arrange for taxi or rideshare services. 

No, SITC does not offer group registration discounts and all attendees must have their own individual meeting registration. If someone would like to pay for multiple attendees, please contact the SITC Meetings Team at events@sitcancer.org.

Yes, there will be a poster hall on site at the 41^st Annual Meeting. Poster hall hours are 10 a.m.–2 p.m. and 5–7 p.m. MST on Friday, Nov. 6, and 10 a.m.–2 p.m. and 6–8:10 p.m. MST on Saturday, Nov. 7, 2026. ePosters are also available for all accepted abstracts through Jan. 7, 2027.

All meeting times listed for SITC 2026 are in Mountain Standard Time (MST).

An electronics-free quiet space will be available in the Phoenix Convention Center-200 Level-223. All attendees are welcome to use this room to meditate, practice religion, reflect, relax, or escape the excitement of SITC events. Please no cell phone use.

Regular and Early Career Investigator Award Abstracts: The submission period is April 22, 2026, through June 25, 2026, at 5 p.m. PT.

Late-Breaking Abstracts - Clinical Only (LBA): The submission period is July 15, 2026, through Sept. 10, 2026, at 5 p.m. PT.

There is no limit to the number of authors that can be included on an abstract. All authors must have at least one institution listed, and there must be a minimum of one corresponding, one primary and one presenting author for each abstract.

Unfortunately, SITC does not accept any Regular or Early Career Investigator Award Abstracts after June 25, 2026 at 5 p.m. PT and does not accept any LBAs after Sept. 10, 2026 at 5 p.m. PT.

You do not need to be a SITC member to submit a Regular or Late-breaking Abstract. You must be a SITC member to be considered for the Early Career Investigator Award.

The only items required to stay within the 400-word count are the background, methods, results, and conclusion. The following items are not included in the 400-word count limit:

• Acknowledgements
• Trial Registration
• References
• Consent
• Ethics Approval
• Authors and Institutions
• Tables, Figures and Images

There is a limit of 2 tables, figures or images that can be included on an abstract. All figures, tables and images must be numbered (i.e.: Table 1, Figure 1, or Image 1) in the title field and cited in the abstract text.

The following items are requested, if applicable, when submitting an abstract:

• Title
• Background
• Methods
• Results
• Conclusions
• Acknowledgements
• Trial Registration
• References
• Consent
• Ethics Approval
• Authors and Institutions
• Tables, Figures and Images

Early Career Investigator Award Abstracts must also include:

• A letter of recommendation from a supervisor (.doc, .docx, .pdf)
• Confirmation they are a SITC member
• Confirmation they are a student, postdoctoral research fellow, clinical fellow, or junior faculty with three or fewer years on staff, and if so, which category they represent
• Percentage of contribution by the primary and presenting author in conception and design, collection and assembly, data analysis and interpretation, and abstract writing

Clinical Trial In Progress and Clinical Trial Complete abstracts must also include:

Abstract submitters must answer whether the abstract is based on a clinical trial presenting clinical data, and mark whether it is an in progress or a completed clinical trial. If the abstract incorporates basic or pre-clinical research, mark that it is not a clinical trial abstract.

Enrollment Report Data Table: Clinical trial abstract submitters are asked to complete the Enrollment Report data table, which follows the NIH data template. This data will not be shared with abstract reviewers and will not be included in the publication of accepted abstracts. It will only be accessible to SITC staff and reported in aggregate.

Late-breaking Abstracts must also include:

• Closure date of the study
• Primary clinical endpoint for analysis
• Type of analysis
• An explanation why the abstract should be considered for late-breaking submission

Once an abstract is submitted, the presenting author is automatically sent an email notification asking them to complete their Conflict of Interest (COI). The email contains a link to the online COI form. They will need to log in to their SITC account to access the form. Should the presenting author have any issues, they can reach out to education@sitcancer.org. The submitting author can check if the COI has been submitted by contacting education@sitcancer.org.

After you have submitted your abstract, you will receive a confirmation email. The presenting author must click the link in that email, which will take them to the online COI form. You will need to log in using your SITC account to access and complete this form.

SITC understands the crucial need for collaboration and discussion surrounding clinical trials in progress. This abstract submission category aims to allow for open dialogue surrounding such trials.

All phases of clinical research may be considered for inclusion. Although there are no absolute criteria, SITC provides the following general guidelines:

Background:

• Scientific background/rationale for the trial should be included
• Preclinical and/or earlier-phase clinical data that has already been publicly presented or published may be included with references
• Abstracts should be written with respect to the correlates and hypothesis being tested in clinical trials

Methods:

• Clinical trial registry number (required, if appropriate)
• Trial design and statistical methods
• Treatment or intervention planned
• Major eligibility criteria, highlighting unusual aspects
• It is not a requirement that the trial be recruiting ("Open but Not Yet Recruiting" is acceptable)

NOT acceptable in a Clinical Trial in Progress abstract:

• Completed trials (these should be submitted in other categories)
• Brand or proprietary drug names

All abstracts submitted under this category are subject to peer review and possible rejection.

Regular and Early Career Investigator Award Abstracts will be notified on July 31, 2026. Late-breaking Abstract notifications will be sent on Sept. 28, 2026. Late-breaking Abstracts not accepted will not have the opportunity to present at SITC.

The deadline for Regular and Early Career Investigator Award abstract withdrawal or changes, including presenter changes, is Aug. 7, 2026.

This deadline is set because abstract information is pulled for publication immediately following this date and cannot be edited after that. Submit withdrawal or change requests in writing to education@sitcancer.org.

For all questions regarding abstracts please contact education@sitcancer.org.

LBA submission is solely for abstracts with late-breaking data from interventional clinical trials in humans — not for abstracts submitted "late." LBAs highlight novel and practice-changing in-human clinical studies, and only apply to data that would not otherwise have been presented as an abstract at the 41^st Annual Meeting.

If a Late-breaking Abstract is not accepted, it will not be published or presented at the meeting. There is no longer an option for it to be considered as a Regular/Early Career Investigator Award Abstract.

Examples of acceptable LBAs (results not available or significant by the regular abstract submission deadline):

• Results of a practice-changing prospective Phase III clinical trial
• Phase II study showing anti-tumor activity in a novel context
• An early in-human clinical trial with novel proof-of-principle data

LBA submission closes on Sept. 10, 2026 at 5 p.m. PT.

No, an application is not required. LBAs should be submitted directly by Sept. 10, 2026 at 5 p.m. PT.

LBAs must address interventional clinical trials in humans. LBAs addressing basic science or translational data with no in-human studies will not be accepted. LBAs may contain data from preclinical studies, but must also include clinical data from in-human trials.

Authors submitting a basic science or translational study must submit their abstract by the Regular/Early Career Investigator Award Abstract deadline of June 25 at 5 p.m. PT. If some results are not yet available, authors are encouraged to submit by the deadline and include the new data in their presentation.

LBAs must include the following in their abstract:

• Closure date of the study
• Primary clinical endpoint for analysis
• Type of analysis
• An explanation why the abstract should be considered for late-breaking submission

Expanded plenary sessions are available for LBA oral presentations at SITC 2026. In addition to oral abstract presentations, oral presenters are invited to present their abstract as a poster and an ePoster as well. ePosters can be uploaded by the presenting author (more information provided in the Speaker Management System).

The deadline for Late-breaking Abstract withdrawal or changes, including presenter changes, is Oct. 5, 2026.

This deadline is set because abstract information is pulled for publication immediately following this date. Submit withdrawal or change requests in writing to education@sitcancer.org.

You may view your submitted abstract by logging into the abstract submission system and clicking on "Abstract Submissions."

After abstracts are reviewed and selected, abstract submitters are sent an email notification stating whether the abstract was accepted and, if so, what type of presentation it was accepted as. The submitter will also be asked to accept or decline participation in SITC 2026.

If SITC does not receive a response by the stated deadline, SITC will assume you agree to present and will include your abstract.

The abstract number is the number assigned by SITC and provided in the notification email. This is the number made public for your abstract. The abstract ID is assigned by the submission site when you submit; it is used for administrative purposes and is not made public.

The abstract number is determined by the category selected when the abstract is submitted and the last name of the primary author.

The abstract number determines where your abstract will be listed in all publications, including the Journal for ImmunoTherapy of Cancer (JITC) Supplement, and on the SITC 2026 website and meeting app. For abstracts selected for poster presentation, it also determines where your poster will be located in the Poster Hall.

Once assigned, abstract numbers cannot be changed.

Yes, the presenting author must register for the Annual Meeting to present an abstract. Submitting an abstract does not register you for the meeting. All presenting authors are responsible for registering themselves and booking their own housing, if needed.

Unfortunately, SITC does not offer free or discounted registration to abstract presenters.

Full Regular and Early Career Investigator Award Abstract content will be embargoed until 9 a.m. ET on Nov. 3, 2026.

Full Late-breaking Abstract (LBA) content will be embargoed until 9 a.m. ET on Nov. 6, 2026. After that, the abstract content will be published in the JITC Supplement. This does not include additional data available on a poster or any updated/new data in oral presentations.

Regular and Early Career Investigator Award Abstract titles will be released on Oct. 2, 2026 on the SITC 2026 website. Late-breaking Abstract titles will be released on Oct. 29, 2026 on the SITC 2026 website.

The deadline for Regular and Early Career Investigator Award Abstract withdrawals, including presenter changes, is Aug. 7, 2026. The deadline for Late-breaking Abstract withdrawals, including presenter changes, is Oct. 5, 2026.

These deadlines are set because the abstract information is pulled for publication immediately following these dates and cannot be edited afterward. Submit requests in writing to education@sitcancer.org.

If you would like to change the presenter before the applicable withdrawal deadline, submit your request in writing to education@sitcancer.org.

Any abstract previously accepted and/or published (by any meeting or publisher) must contain substantial new data in order to be considered. This includes Trial in Progress abstracts. Contact education@sitcancer.org if you have questions about substantial new data.

Both oral and poster abstract presenters will be informed of their presentation details in their notification email sent on July 31, 2026 for Regular and Early Career Investigator Award Abstracts and Sept. 28, 2026 for Late-breaking Abstracts.

Oral Abstract Presenter:

• Presenter's photo
• Presenter's Conflict of Interest disclosure form
• PowerPoint presentation slides
• Completed recording permission form
• An image for the ePoster

Rapid Oral Abstract Presenter:

• Presenter's photo
• Presenter's conflict of interest disclosure form
• PowerPoint presentation slides
• Completed recording permission form
• An image for the ePoster

Poster Abstract Presentation:

• Printed poster for onsite display
• An image of the poster for the ePoster

All abstract PowerPoint presentations are due Oct. 23, 2026.

All presentations are needed prior to the meeting for review to ensure they follow the guidelines given to the author.

A Faculty Resource Room will be available onsite during SITC 2026 for presenters to upload updated slides. All faculty are required to load final presentation slides at least 48 hours before the start of the program in which they are presenting. Please note there may be a wait time for uploading slides — plan accordingly.

Slides will be kept confidential until the embargo is lifted at the time of the presentation. Presentation slides may be made available to meeting attendees if permission to publish the slides is received from the presenter per the recording permission form.

Yes, there will be a microphone as well as a screen for a short presentation for oral abstract and poster symposium presentations.

The Poster Hall location is PCC - Lower Level - North Exhibition Halls 4-5-6.

Poster specifications will be included in the notification emails sent on Friday, July 31, 2026 for Regular and Early Career Investigator Award abstracts and Monday, Sept. 28, 2026 for LBAs.

Friday, Nov. 6, 2026 – Odd Numbered Posters

• Poster Hall Hours: 10 a.m. – 2 p.m., 5 – 7 p.m. MST
• Set Up: 9–10 a.m. (hall is officially closed; please depart after hanging your poster)
• Tear Down: After 7 p.m. MST
• Required Hours: Lunch (12:15–1:45 p.m.) and Poster Reception (5:30–7 p.m.)
• Additional Hours Encouraged: Morning Break (9:10–9:40 a.m.)

Saturday, Nov. 7, 2026 – Even Numbered Posters

• Poster Hall Hours: 10 a.m.–2 p.m., 6–8:10 p.m. MST
• Set Up: 9–10 a.m. (hall is officially closed; please depart after hanging your poster)
• Tear Down: After 8:10 p.m. MST
• Required Hours: Lunch (12:15–1:45 p.m.) and Poster Reception (6:40–8:10 p.m.)
• Additional Hours Encouraged: Morning Break (9:05–9:35 a.m.)

Odd numbered posters will be on display on Friday, Nov. 6, 2026 from 10 a.m.–2 p.m. and 5–7 p.m. MST. Even numbered posters will be on display on Saturday, Nov. 7, 2026 from 10 a.m.–2 p.m. and 6–8:10 p.m. MST. This applies to Regular, Early Career Investigator Award, and Late-breaking Abstract posters.

The Poster Hall will be open 10 a.m.–2 p.m. and 5–7 p.m. MST on Friday, Nov. 6 and 10 a.m.–2 p.m. and 6–8:10 p.m. MST on Saturday, Nov. 7. Authors must be present during lunch and reception hours on their assigned day, and are strongly encouraged to stand by their posters during all breaks.

Friday, Nov. 6 – Odd Poster Numbers: Required during Lunch (12:15–1:45 p.m.) and Poster Reception (5:30–7 p.m.). Also encouraged during Morning Break (9:10–9:40 a.m.).

Saturday, Nov. 7 – Even Poster Numbers: Required during Lunch (12:15–1:45 p.m.) and Poster Reception (6:40–8:10 p.m.). Also encouraged during Morning Break (9:05–9:35 a.m.).

No, posters do not need to have the poster number printed on them. Poster numbers will be displayed on the poster boards.

Unfortunately, SITC does not provide any recommendations or accommodations for printing posters onsite at the Annual Meeting. SITC suggests bringing your poster with you while traveling.

SITC does not provide any recommendations or accommodations for shipping or disposing of posters. The presenting author must bring the poster with them to the meeting. Posters left in the Poster Hall on Saturday, Nov. 7, 2026 will be disposed of by the convention center staff.

Providing your poster as an ePoster is required. Abstract ePosters will be available to attendees on SITC 2026's Virtual Platform beginning Friday, Nov. 6, 2026. Everyone with an accepted abstract is required to submit an ePoster. Those attending in person are also asked to bring a physical poster for the Poster Hall. SITC will not print posters for authors. Additional submission requirements are provided in the presenting author’s Speaker Center. If you need assistance accessing your Speaker Center, please contact education@sitcancer.org.

Poster presenters retain the right to reuse their poster after the poster embargo lifts on Nov. 6 at 9 a.m. ET. ePosters will remain on the SITC virtual meeting platform through Jan. 7, 2027. SITC does not distribute or display ePosters anywhere after Jan. 7, 2027.

Yes, oral presenters are invited to present their abstract as a poster and an ePoster as well. ePosters can be uploaded by the presenting author (more information provided in the Speaker Management System).

Yes, posters can provide additional information either as a printed handout or by including a link or QR code on the poster. Additional information can also be provided by uploading a handout in the SITC Abstract Management System.

Yes, however any planned press releases and media alerts must be reviewed and approved in advance by SITC Communications staff and must follow the Embargo Policy. Please allow a minimum of two business days for review. Drafts should be emailed to communications@sitcancer.org.